D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
4051
DELISTED
bluebird bio
BLUE
| $407K | ﹤0.01% |
+1,644
| New | +$470K |
|
|
ONEM
4052
CALL
DELISTED
1Life Healthcare
ONEM
| $405K | ﹤0.01% |
+20,000
| New | +$514K |
|
|
SCWX
4053
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $404K | ﹤0.01% |
20,306
+8,861
| +77% | +$183K |
|
|
TWOA
4054
DELISTED
two
TWOA
| $404K | ﹤0.01% |
+41,309
| New | +$403K |
|
|
HNGR
4055
DELISTED
Hanger Inc.
HNGR
| $404K | ﹤0.01% |
18,396
-6,737
| -27% | -$156K |
|
4056
Merchants Bancorp
MBIN
$2.24B
| $403K | ﹤0.01% |
15,314
-10,995
| -42% | -$273K |
|
|
YQ
4057
17 Education & Technology Group
YQ
$20.8M
| $402K | ﹤0.01% |
22,325
-24,610
| -52% | -$732K |
|
4058
Mondelez International
MDLZ
$81.3B
| $401K | ﹤0.01% |
6,892
-43,474
| -86% | -$2.7M |
|
4059
Stereotaxis
STXS
$126M
| $401K | ﹤0.01% |
74,532
+50,754
| +213% | +$383K |
|
4060
Cardlytics
CDLX
$22.1M
| $399K | ﹤0.01% |
476
-30
| -6% | -$30.4K |
|
4061
Qfin Holdings
QFIN
$1.63B
| $399K | ﹤0.01% |
19,612
-14,911
| -43% | -$352K |
|
4062
RPC Inc
RES
$1.17B
| $398K | ﹤0.01% |
81,875
-15,436
| -16% | -$64.6K |
|
4063
i3 Verticals
IIIV
$418M
| $397K | ﹤0.01% |
16,417
+4,007
| +32% | +$116K |
|
|
DFTX
4064
Definium Therapeutics
DFTX
$5.43B
| $397K | ﹤0.01% |
11,368
+2,514
| +28% | +$109K |
|
4065
CALL
Tencent Music
TME
$15.5B
| $397K | ﹤0.01% |
54,700
-296,000
| -84% | -$2.9M |
|
4066
LifeVantage
LFVN
$79.9M
| $396K | ﹤0.01% |
58,585
+41,563
| +244% | +$306K |
|
4067
Chunghwa Telecom
CHT
$33.5B
| $395K | ﹤0.01% |
10,060
-50,884
| -83% | -$2.08M |
|
4068
MoonLake Immunotherapeutics
MLTX
$1.63B
| $395K | ﹤0.01% |
40,053
+17,040
| +74% | +$170K |
|
|
AAIC
4069
DELISTED
Arlington Asset Investment Corp.
AAIC
| $395K | ﹤0.01% |
106,858
+16,017
| +18% | +$61.1K |
|
4070
NVE Corp
NVEC
$548M
| $394K | ﹤0.01% |
6,157
-1,117
| -15% | -$79.4K |
|
|
PSPC.WS
4071
DELISTED
Post Holdings Partnering Corporation Redeemable Warrants, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50
PSPC.WS
| $393K | ﹤0.01% |
+436,666
| New | +$572K |
|
4072
Vital Farms
VITL
$590M
| $392K | ﹤0.01% |
+22,291
| New | +$400K |
|
4073
Arcos Dorados Holdings
ARCO
$1.76B
| $390K | ﹤0.01% |
76,123
-73,676
| -49% | -$415K |
|
4074
eHealth
EHTH
$42.9M
| $389K | ﹤0.01% |
9,609
+5,019
| +109% | +$234K |
|
4075
Towne Bank
TOWN
$3.51B
| $388K | ﹤0.01% |
+12,483
| New | +$376K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.